Fetal Chromosomal Aneuploidy Test Kit (T21, T18, T13)

NIPT is a prenatal screening method that uses high-throughput gene sequencing and molecular genetic techniques to detect fetal cell-free DNA fragments in maternal peripheral blood, assessing the risk of common fetal chromosomal aneuploidies (T21, T18, T13). The test extracts free DNA from maternal blood containing fetal genetic information and analyzes it through high-throughput sequencing to detect abnormalities in fetal chromosome number and structure. Compared to traditional maternal serum screening, NIPT offers advantages of high detection rate and low false positive rate, while avoiding the risks associated with invasive methods such as amniocentesis.

A closed system, ready-to-use, clinically validated PCR-based assay panel for assessing chromosomal aneuploidy including T21, T18, T13, and sex chromosomes X and Y. It is specifically tailored for non-invasive prenatal testing applications.

A prenatal diagnostic test for the detection of chromosomal number abnormalities in the fetus.

A diagnostic kit for detecting chromosomal aneuploidy in embryos prior to implantation. The kit comes in 50 samples per box with a 6-month validity period and is identified by catalogue number J000001. It is used in clinical reproductive genetics for embryo screening.

Molecular diagnostic test for prenatal screening and fetal abnormality detection. Assesses risk for genetic and chromosomal disorders.

A comprehensive solution for prenatal testing including reagent kits and equipment for DNA sequencing and bioinformatic analysis. Sensitivity greater than 99% for detection of trisomies 21, 18, and 13, with capability to identify up to 100 genetic conditions and produce results within 14 hours.

Biochemical markers and cell-free DNA assay systems for fetal abnormality screening. Used in first and second trimester screening programs.

FISH probe kits for prenatal cytogenetic testing to detect chromosomal abnormalities.

A diagnostic test kit designed to detect fetal fibronectin in cervical samples to assess preterm birth risk. The kit helps identify pseudo-threatened preterm birth and provides scientific measurement for comprehensive evaluation of fetal health. It uses advanced detection methodology to distinguish between threatened preterm labor and false positives, reducing unnecessary clinical interventions.

Non-invasive prenatal testing panel for fetal genetic and chromosomal abnormality screening. This test supports optimal pregnancy outcomes through early detection of maternal and fetal health risks. The product is part of the company's maternal-fetal medicine offerings.

A diagnostic kit for counting and analyzing fetal cells in maternal circulation. Used in prenatal diagnosis to detect and quantify fetal cells for assessment of maternal-fetal hemorrhage and fetal status. Available variants: Fetal Cell Count™ Kit.

Next-generation non-invasive prenatal testing kit for screening common genetic conditions in singleton, twin, and IVF pregnancies. Utilizes proprietary sequencing technology with automated workflow capabilities for high-throughput prenatal screening.